TrialJournal for immunotherapy of cancer2017

Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma.

Anna Laurell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.